|Previous Section||Index||Home Page|
Sarah Teather: To ask the Secretary of State for Health how many (a) clinical and (b) non-clinical NHS staff were employed in (i) Brent and (ii) each London primary care trust in each year since 1997. 
Jane Kennedy: The number of clinical and non-clinical national health service staff employed in each constituency and primary care trust is not collected centrally. However, data collected by strategic health authority for the years 1997 to 2004 is available and has been placed in the Library.
Ms Rosie Winterton: Most national health service dentistry is provided by self-employed dentists, who employ their own dental nurses. As a result, information is not held centrally on numbers of dental nurses working in dental practices providing general dental services under the NHS.
Mr. Burstow: To ask the Secretary of State for Health if she will list local authorities in England which have established (a) adult protection policies and (b) adult protection committees following publication of the No Secrets guidance. 
Jane Kennedy: Figures for the numbers of children diagnosed as obese in each London borough are not collected centrally. However, figures on the prevalence of obesity are available by Government office region from the Health Survey for England. This data is available in table 5 on the Department's website at www.dh.gov.uk/assetRoot/04/10/94/11/0410941l.pdf.
Sarah Teather: To ask the Secretary of State for Health how many pharmacies operated 24 hour services in each year since 1997 in (a) Brent East, (b) Brent and (c) each London primary care trust. 
Jane Kennedy: Information on the number of community pharmacies by constituency is not collected centrally. However, information prior to 2002 is available by health authority (HA) and from 2002 by primary care trust (PCT). This data is shown in the tables.
|Number of community pharmacies|
|Brent and Harrow||136||134||131||130||129|
|Ealing, Hammersmith and Hounslow||168||165||166||163||161|
|Kensington, Chelsea and Westminster||152||152||150||148||148|
|Enfield and Haringey||117||117||116||116||(29)194|
|Camden and Islington||112||112||111||111||111|
|Barking and Havering||83||81||80||79||79|
|East London and City||169||169||169||167||166|
|Redbridge and Waltham Forest||109||109||109||108||108|
|Bexley and Greenwich||94||94||94||94||(30)151|
|Lambeth, Southwark and Lewisham||178||176||176||174||174|
|Kingston and Richmond||76||76||76||75||75|
|Merton, Sutton and Wandsworth||149||147||145||145||143|
|Number of community|
|Primary care trust||200203||200304|
|Hammersmith and Fulham||41||40|
|Kensington and Chelsea||41||41|
|Barking and Dagenham||36||35|
|City and Hackney||65||65|
|Chingford, Wanstead and Woodford||23||(31)n/a|
|Walthamstow, Leyton and Leytonstone||46||(32)n/a|
|Richmond and Twickenham||45||45|
|Sutton and Merton||77||77|
Lynne Featherstone: To ask the Secretary of State for Health if she will list the health (a) authorities and (b) trusts in England providing funding for anti-TNF therapy for people with rheumatoid arthritis; and if she will make a statement. 
Health bodies are obliged to fund, from general allocations, anti-TNF (tumour necrosis factor) treatment for those with severe rheumatoid arthritis who meet the clinical guidelines set by the National Institute for Health and Clinical Excellence.
13 Jun 2005 : Column 110W
Mr. Lansley: To ask the Secretary of State for Health if she will make a statement on the availability of Zoledronate in the NHS to treat secondary bone cancer; and if she has plans to direct the National Institute for Health and Clinical Excellence to conduct an appraisal of the treatments available for the management of secondary bone cancer. 
Zoledronic acid belongs to the class of drug known as bisphosphonates and is licensed in the United Kingdom for the prevention of skeletal related events in patients with advanced malignancies involving bone and for the treatment of tumour-induced hypercalcaemia.
|Next Section||Index||Home Page|